Rockefeller Capital Management’s Kailera Therapeutics KLRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.4K Buy
+1,000
New +$16.9K ﹤0.01% 4120

Other funds holding KLRA

Rockefeller Capital Management's KLRA Position: Q3 2026 in Review

Rockefeller Capital Management opened a new position in Kailera Therapeutics (KLRA) in Q3 2026: 1,000 shares worth $11.4K. The stake represents ﹤0.01% of the portfolio and ranks #4120 among its holdings.

132 funds tracked by Wall St. Rank hold KLRA as of Q3 2026.

  • Rockefeller Capital Management held 1,000 shares of Kailera Therapeutics worth $11.4K as of Q3 2026.
  • Kailera Therapeutics was a new Rockefeller Capital Management position in Q3 2026.
  • Kailera Therapeutics made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #4120 holding.
  • 132 funds tracked by Wall St. Rank held Kailera Therapeutics as of Q3 2026.

Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.